Dermira

Eli Lilly axes 163 Dermira staffers, shutters Menlo Park site as it closes in around Dupixent rival lebrikizumab
Endpoints
Thu, 04/15/21 - 10:39 am
Eli Lilly
Dermira
Qbexza
layoffs
Biopharma acquisitions slow, but it's not Covid-19's fault yet
EP Vantage
Wed, 04/8/20 - 10:28 am
M&A
COVID-19
Gilead Sciences
Forty Seven
Eli Lilly
Dermira
Takeda
Hypera Pharma
ANI Pharmaceuticals
Amerigen Pharma
Eli Lilly Bags Dermatology Company Dermira for $1.1 Billion
BioSpace
Fri, 01/10/20 - 10:43 am
Eli Lilly
Dermira
dermatology
M&A
atopic dermatitis
Dermira shares double on positive eczema data
Biopharma Dive
Mon, 03/18/19 - 05:03 pm
Dermira
lebrikizumab
clinical trials
eczema
No sweat? Dermira snags reps, sets price and plots branded ads for Qbrexza launch
Fierce Pharma
Wed, 09/5/18 - 06:34 pm
Dermira
Qbrexa
drug launches
Acne was a bust, but excessive sweating scores FDA OK for Dermira — shares climb
Endpoints
Fri, 06/29/18 - 10:25 am
Dermira
FDA
glycopyrronium
Qbrexza
excessive sweating
Dermira acne drug misses the mark, surprising investors
Biopharma Dive
Mon, 03/5/18 - 02:51 pm
Dermira
acne
DRM01
5 Major Clinical Trial Results Coming Up
24/7 Wall St
Wed, 05/25/16 - 09:19 pm
clinical trials
Vertex Pharmaceuticals
Orkambi
Puma Biotechnology
neratinib
GW Pharma
Epidiolex
Agios Pharmaceuticals
AG-348
AG-519
Dermira
DRM-04
9 Biotech Picks for 2016
Barron's
Sat, 01/2/16 - 10:19 am
biotech
Adaptimmune
Dermira
FibroGen
Incyte
Intra-Cellular Therapies
Seres Therapeutics
Ophthotech
Neurocrine Biosciences
Paratek
Two new biotech IPOs help set the stage for the fall parade
Fierce Biotech
Thu, 08/28/14 - 11:04 am
IPOs
Rhythm Pharmaceuticals
Dermira
Start-up Dermira secures $42M A round, acquires Valocor Therapeutics
Fierce Biotech
Fri, 10/21/11 - 10:52 am
Dermira
Valocor Therapeutics